INFLAMATORY BOWEL DISEASE (CROHN'S AND ULCERATIVE COLITIS)
Clinical trials for INFLAMATORY BOWEL DISEASE (CROHN'S AND ULCERATIVE COLITIS) explained in plain language.
Never miss a new study
Get alerted when new INFLAMATORY BOWEL DISEASE (CROHN'S AND ULCERATIVE COLITIS) trials appear
Sign up with your email to follow new studies for INFLAMATORY BOWEL DISEASE (CROHN'S AND ULCERATIVE COLITIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Crohn's patients: drug switch shows promise
Disease control Recruiting nowThis study looks at whether a drug called guselkumab can help people with moderate to severe Crohn's disease who did not get better with or could not tolerate another drug called ustekinumab. About 60 adults will take guselkumab for a year, and researchers will check if their sym…
Matched conditions: INFLAMATORY BOWEL DISEASE (CROHN'S AND ULCERATIVE COLITIS)
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 26, 2026 06:46 UTC
-
Hidden kidney risk in IBD patients under investigation
Knowledge-focused Recruiting nowThis study looks at whether people with inflammatory bowel disease (Crohn's or ulcerative colitis) have more kidney problems than the general population. Researchers will compare 3,000 IBD patients with 3,000 healthy volunteers using blood tests, urine tests, and kidney imaging. …
Matched conditions: INFLAMATORY BOWEL DISEASE (CROHN'S AND ULCERATIVE COLITIS)
Sponsor: Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji • Aim: Knowledge-focused
Last updated May 26, 2026 06:48 UTC